» Articles » PMID: 34370174

Ocular Toxoplasmosis: a Review of the Current Diagnostic and Therapeutic Approaches

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 2021 Aug 9
PMID 34370174
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This review aims to summarize the current knowledge concerning the clinical features, diagnostic work-up and therapeutic approach of ocular toxoplasmosis focusing mainly on the postnatally acquired form of the disease.

Methods: A meticulous literature search was performed in the PubMed database. A supplementary search was made in Google Scholar to complete the collected items.

Results: Ocular toxoplasmosis is one of the most frequent infectious etiologies of posterior uveitis. It typically presents with retinochoroiditis. Setting an accurate diagnosis depends to a considerable degree on detecting characteristic clinical characteristics. In addition to the evaluation of clinical features, the diagnosis of toxoplasmosis relies at a large degree on serologic testing. The detection of the parasite DNA in the aqueous or vitreous humor can provide evidence for a definitive diagnosis. The current mainstay for the treatment, if necessary, is the use of oral antibiotic with systemic corticosteroids. Recent evidence suggests other therapeutic approaches, such as intravitreal antibiotics can be used.

Conclusion: Recent developments in the diagnostic and therapeutic approach have contributed to preventing or limiting vision loss of patients suffering from ocular toxoplasmosis. Further studies are required to provide a better understanding of epidemiology, pathogenesis, diagnosis, and treatment with a significant impact on the management of this challenging clinical entity.

Citing Articles

Association of ADHD and LD with vision abnormalities among the children and adolescents in US, NHANES 1999-2004.

Lu J, Zhou K, Liang Y, Li Q, Zhong J, Zeng X Front Neurol. 2025; 16:1465444.

PMID: 40066313 PMC: 11891056. DOI: 10.3389/fneur.2025.1465444.


Clinical Manifestations of Ocular Toxoplasmosis in Hubei, China: Case Series.

Li M, Zhang X, Yan X, Li P Curr Med Sci. 2025; .

PMID: 40053304 DOI: 10.1007/s11596-025-00028-0.


T-cell activation of Toxoplasma gondii positive donors by maltodextrin nanoparticles formulated with killed Toxoplasma gondii.

Vargas-Montes M, Fasquelle F, Cardona N, Gomez-Marin J, Betbeder D BMC Infect Dis. 2025; 25(1):279.

PMID: 40011842 PMC: 11866635. DOI: 10.1186/s12879-025-10656-5.


Quantitative levels of interferon gamma as a biomarker in the aqueous and serum samples of infectious and noninfectious uveitis patients.

Shaban S, Safwat H, Abdelmohymen A, Hassan D, Mansour M, Mohammed H J Ophthalmic Inflamm Infect. 2025; 15(1):12.

PMID: 40000515 PMC: 11861789. DOI: 10.1186/s12348-025-00461-1.


Artificial Intelligence-Based Uveitis Diagnosis Through Retinal Vasculature Analysis: A Paradigm Shift in Ocular Tuberculosis.

Putera I, Quiros J, Rombach S, Dik W, van Hagen P, La Distia Nora R Ophthalmol Ther. 2025; .

PMID: 39992617 DOI: 10.1007/s40123-025-01103-4.


References
1.
Schuman J, Weinberg R, FERRY A, Guerry R . Toxoplasmic scleritis. Ophthalmology. 1988; 95(10):1399-403. DOI: 10.1016/s0161-6420(88)32998-2. View

2.
Cunha de Souza E, Casella A . Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. Arch Ophthalmol. 2009; 127(10):1390-4. DOI: 10.1001/archophthalmol.2009.251. View

3.
Hogan M . Ocular toxoplasmosis. Am J Ophthalmol. 1958; 46(4):467-94. DOI: 10.1016/0002-9394(58)91127-9. View

4.
Holland G . Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004; 137(1):1-17. View

5.
OConnor Jr W, Kamanaka M, Booth C, Town T, Nakae S, Iwakura Y . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603-9. PMC: 2709990. DOI: 10.1038/ni.1736. View